Hearing hope: 1,260 volunteers sought to unlock secrets of auditory training

NCT ID NCT06812273

First seen Jun 24, 2026 · Last updated Jun 24, 2026

Summary

This study is testing whether auditory training can help people, especially older adults, understand speech in noisy environments. Researchers will compare different training methods in 1,260 participants aged 18-30 and 60-85. The goal is to find out which approaches work best and what personal factors influence success.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEARING HANDICAP are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Northeastern University

    RECRUITING

    Boston, Massachusetts, 02115, United States

    Contact

    Contact Email: •••••@•••••

  • Oregon Health & Science University

    RECRUITING

    Portland, Oregon, 97239, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University of California, Riverside

    RECRUITING

    Riverside, California, 92521, United States

    Contact Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

auditory training (behavioral intervention)

What this could lead to

If successful, this could identify the most effective auditory training methods to help people hear better in noisy settings, potentially improving quality of life and reducing cognitive decline risk.

What could go wrong

This is an early-stage observational study, not testing a new drug or device. Results may not apply to everyone, and individual outcomes can vary widely.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.